HPS Underlines Growth with St Vincent’s Contract
HPS has celebrated 15 months since the investment by private equity firm Blue Sky Alternative Investments with another major national contract win.
The contract to supply the St Vincent’s Health Australia group of private hospitals across the eastern states, combined with the extension of a national contract with Healthscope Hospitals and other recent contract wins with various clients, means Adelaide-based HPS has now increased the contract revenue pipeline by more than $980 million over the next decade.
HPS Chief Executive Officer Tony Wyatt said the company’s focus on innovation and service had been the cornerstones of its success.
“Hospitals are looking for a pharmacy partner they can trust to help them care for their patients,” he said.
“That’s based not only on the products and service but also the thought-leadership you can bring to the partnership.
“We are very fortunate to have developed outstanding relationships, and our track record is helping us build on that success.
“St Vincent’s Health Australia is the nation’s largest Catholic not-for-profit health and aged care provider, and we are delighted to be partnering with them across so many of their sites.”
Having started business in Adelaide 40 years ago, HPS is now the country’s largest independent provider of pharmacy services to private hospitals, public hospitals, and cancer centres.
Mr Wyatt said the company was also one of the most committed to technological innovation in the sector.
“We have invested significantly in developing our electronic infrastructure to enable us to meet the unique needs of our clients,” he said.
“Examples of this investment include the deployment of i.Pharmacy, dispensary automation, data exchange and management, and our proprietary ClinPod® clinical reporting tool.”
Mr Wyatt said the company’s future plans included investigating more public-private partnership opportunities and continued investment in facilities.